Moody Aldrich Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Moody Aldrich Partners's RGEN Position: Q4 2024 in Review
Moody Aldrich Partners sold out of Repligen (RGEN) in Q4 2024, closing a stake of 1,505 shares — an estimated $224K sold.
Moody Aldrich Partners first reported a position in RGEN in Q3 2019 and held it in 18 quarters. The position peaked at $5.19M in Q2 2022. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.
- Moody Aldrich Partners reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
- Moody Aldrich Partners sold 1,505 Repligen shares in Q4 2024, an estimated $224K.
- Moody Aldrich Partners first reported a position in Repligen in Q3 2019 and held it in 18 quarters.
- Moody Aldrich Partners's Repligen position peaked at $5.19M in Q2 2022.
- 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.
Based on Moody Aldrich Partners's 13F filing for Q4 2024, filed 23 Jan 2025.